Related Experiment Video
Updated: Apr 16, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Congenital Chagas disease: an update
Yves Carlier1, Sergio Sosa-Estani2, Alejandro O Luquetti3
1Faculté de Médecine, Université Libre de Bruxelles, Bruxelles, Belgique.
Congenital Trypanosoma cruzi infection affects 5% of newborns in endemic areas. Early diagnosis and treatment in pregnant women and infants are crucial for prevention and effective management of Chagas disease.
Area of Science:
- Infectious Diseases
- Parasitology
- Global Health
Background:
- Congenital Trypanosoma cruzi infection is a significant global health concern, impacting approximately 5% of infants born to infected mothers in endemic regions.
- Prevalence varies geographically, highlighting the need for region-specific epidemiological data.
Purpose of the Study:
- To update epidemiological data on congenital Trypanosoma cruzi infection.
- To review research methods, contributing factors, and strategies for control and prevention.
- To emphasize the importance of early diagnosis and treatment for congenital Chagas disease.
Main Methods:
- Review of epidemiological data and research methodologies.
- Discussion of diagnostic advancements, including polymerase chain reaction (PCR) for neonates.
- Exploration of preventative strategies, such as maternal treatment before pregnancy.
Main Results:
- Early etiological treatment (before age one) is highly effective in children.
- Integrating congenital Trypanosoma cruzi infection screening into existing maternal health programs (e.g., syphilis, HIV) is recommended.
- PCR testing one month post-birth can enhance neonatal diagnosis.
Conclusions:
- Congenital Trypanosoma cruzi infection requires enhanced surveillance and diagnostic standards in pregnant women and newborns.
- Preventative measures, including pre-conception maternal treatment, show promise.
- Further research into parasite genotypes and host genetics is needed to refine risk assessment and understand disease impact.
Related Concept Videos
Cytomegalovirus Disease
Bacterial Phylum Chlamydiae
Rheumatic Heart Disease I: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy

